These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A consistent approach to platelet transfusion in the NICU. Del Vecchio A; Motta M; Radicioni M; Christensen RD J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779 [TBL] [Abstract][Full Text] [Related]
4. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit. Vamvakas EC; Hitzler WE Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342 [TBL] [Abstract][Full Text] [Related]
6. New strategies for the optimal use of platelet transfusions. Blajchman MA; Slichter SJ; Heddle NM; Murphy MF Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082 [TBL] [Abstract][Full Text] [Related]
7. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Apelseth TO; Hervig T; Bruserud O Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823 [TBL] [Abstract][Full Text] [Related]
8. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Stanworth SJ; Hyde C; Brunskill S; Murphy MF Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920 [TBL] [Abstract][Full Text] [Related]
11. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES. Gubanova MN; Ayupova RF; Zhiburt EB Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588 [TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia and platelet transfusions in patients with cancer. Valent J; Schiffer CA Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961 [TBL] [Abstract][Full Text] [Related]
13. Platelet transfusion goals in oncology patients. Fasano RM; Josephson CD Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759 [TBL] [Abstract][Full Text] [Related]
14. Platelet transfusions for patients with haematological malignancies: who needs them? Estcourt LJ; Stanworth SJ; Murphy MF Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375 [TBL] [Abstract][Full Text] [Related]
15. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation. Schiffer CA Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734 [No Abstract] [Full Text] [Related]
16. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530 [TBL] [Abstract][Full Text] [Related]